CHATSWORTH, Calif.--(BUSINESS WIRE)--IRIS INTERNATIONAL, INC. (NASDAQ GM: IRIS), a leading developer, manufacturer and marketer of medical devices, diagnostic systems and consumables, today announced that it has filed a shelf registration statement on Form S-3 with the Securities and Exchange Commission (SEC) which, when declared effective by the SEC, will allow IRIS from time to time to offer and sell up to $125 million of common stock, preferred stock and debt securities. The terms of any offering made pursuant to this filing will be established at the time of the offering. IRIS would use the proceeds from the sale of any securities for product development, to finance potential acquisitions and investments in companies or products that are complementary to the Company’s business if and when suitable opportunities arise, and for general corporate purposes.
